K4 Elite logo K4 Elite
Home / Peptide Library / Sermorelin
Well Researched

Sermorelin

Hormonal & Endocrine · ['GRF (1-29)', 'GHRH (1-29)', 'Sermorelin acetate', 'Geref']

A 29-amino-acid growth-hormone-releasing hormone analog studied for its ability to stimulate endogenous GH secretion via the GHRH receptor.

🔬 Research use only — not for human or veterinary use. K4 Elite does not provide dosing instructions.
Molecular Formula
C149H246N44O42S
Molecular Weight
3357.9 g/mol
PubChem
CID 16132413 ↗
Research Level
Well Researched
Available in our store →
Sermorelin chemical structure

Sermorelin is a synthetic peptide corresponding to the first 29 amino acids of human growth-hormone-releasing hormone (GHRH), the shortest fragment retaining full biological activity of the native hormone. It has been widely studied as a probe of the hypothalamic-pituitary growth-hormone axis.

Because it acts upstream at the pituitary rather than supplying growth hormone directly, sermorelin has been used in research to evaluate pituitary GH reserve and the physiology of pulsatile GH release. A pharmaceutical formulation was historically marketed for diagnostic and growth-related applications.

It remains a reference compound in endocrine research investigating GH secretagogue physiology and age-related changes in the GH/IGF-1 axis.

Sermorelin binds the growth-hormone-releasing hormone receptor (GHRHR) on pituitary somatotroph cells, a G-protein-coupled receptor that raises intracellular cyclic AMP and stimulates synthesis and pulsatile release of endogenous growth hormone.

Because it works through the native regulatory pathway, its effect is subject to negative feedback from somatostatin and IGF-1, which studies note preserves the physiologic pulsatility of GH secretion compared with direct hormone administration.

  • Assessment of pituitary growth-hormone reserve as a diagnostic research tool [1]
  • Investigation of the GH/IGF-1 axis and its decline with aging [2]
  • Study of GHRH-receptor signaling and somatotroph physiology [1]
  • Evaluation in pediatric growth-hormone deficiency models and trials [3]
  • Exploration of sleep architecture and slow-wave sleep in relation to GH pulsatility [2]
📋 How published studies were conducted — a research reference summarizing study designs from the literature. This is not usage, dosing, or administration guidance. K4 Elite does not provide dosing instructions; determining any research protocol is the sole responsibility of the qualified researcher.

Pituitary GH reserve testing (human) [1]: Clinical studies administered sermorelin and serially measured serum GH to characterize somatotroph responsiveness, establishing dose-response relationships used as a diagnostic reference.

Aging GH axis (human) [2]: Research in older adults measured GH and IGF-1 responses to GHRH analogs, reporting attenuated but restorable GH pulsatility relative to younger cohorts and examining associations with body composition endpoints.

Pediatric growth deficiency (human trial) [3]: Controlled trials in children with growth-hormone deficiency measured growth velocity and IGF-1 over treatment periods to assess whether GHRH-based stimulation improved monitored growth outcomes.

Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.

GHRP-6 / GHRP-2Synergistic
Ghrelin-receptor secretagogues studied alongside GHRH analogs where combined GH release exceeded either alone in models.
SomatostatinCaution
Physiologic inhibitor of GH release that opposes sermorelin action in study designs.
CJC-1295Synergistic
A longer-acting GHRH analog studied in the same secretagogue research category.
GlucocorticoidsCaution
Reported in the literature to blunt GH responses, a consideration in experimental interpretation.
  1. Prakash & Goa, Sermorelin review (BioDrugs)
  2. Corpas et al., Human growth hormone and aging (Endocr Rev)
  3. Thorner et al., GHRH in GH-deficient children (J Clin Endocrinol Metab)
  4. PubChem CID 16132413 (Sermorelin)
What is Sermorelin?
It is a synthetic analog of the first 29 amino acids of human GHRH, studied as a stimulator of endogenous growth-hormone release.
How does it differ from growth hormone itself?
It acts on the pituitary GHRH receptor to prompt the body's own GH secretion, so studies note it preserves the natural pulsatile pattern subject to feedback.
What has research focused on?
Applications include probing pituitary GH reserve, studying the aging GH/IGF-1 axis, and pediatric growth-deficiency trials.
What receptor does it target?
The growth-hormone-releasing hormone receptor (GHRHR), a G-protein-coupled receptor on pituitary somatotrophs.
Is this product for personal use?
No. It is supplied strictly for laboratory research and is not intended for human or veterinary use, diagnosis, or treatment.
Disclaimer: This profile summarizes published preclinical and laboratory research for reference only. It is not medical advice and makes no claim of safety or efficacy in humans. Determining any research protocol is the sole responsibility of the qualified researcher. Products are sold strictly for in-vitro research and have not been evaluated by the FDA.